Bio-Techne (TECH) Total Debt Growth (3y) (2017 - 2026)
Powered by 
Analysis
Bio-Techne (TECH) Total Debt Growth (3y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 0.08% |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 19.52% |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | 4.76% |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -22.30% |
| 10 | Bio-Techne | 11.29 Bn | 11.03 Bn | 211.39 Mn | -17.29% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17.29% |
| Mar 31, 2026 | -18.92% |
| Dec 31, 2025 | 9.14% |
| Sep 30, 2025 | 3.31% |
| Jun 30, 2025 | 10.50% |
| Mar 31, 2025 | 8.13% |
| Dec 31, 2024 | 2.07% |
| Sep 30, 2024 | -0.05% |
| Jun 30, 2024 | -2.31% |
| Mar 31, 2024 | 21.77% |
| Dec 31, 2023 | 24.52% |
| Sep 30, 2023 | 10.93% |
| Jun 30, 2023 | -0.30% |
| Mar 31, 2023 | -3.67% |
| Dec 31, 2022 | -19.47% |
| Sep 30, 2022 | -17.59% |
| Jun 30, 2022 | -20.23% |
| Mar 31, 2022 | -20.64% |
| Dec 31, 2021 | -19.73% |
| Sep 30, 2021 | -18.82% |